Pfizer Inc. recently agreed to an enormous $2.3 billion settlement related to a criminal case, with the Justice Department obtaining the largest fine it has ever issued for health care fraud. The settlement concerns a series of charges involving the misbranding of drugs by the pharmaceutical giant and its subsidiary Pharmacia & Upjohn Inc.
Bruce Barket of Quadrino Schwartz was interviewed by Inside Counsel Magazine regarding the size of the fine and the proportionality of it concerning Pfizer's ability to pay it. The fine needed to make a statement, especially when there were several business units involved in the fraud over an extended period of time.
Barket is the leader of the White Collar Criminal Defense & Investigations Group at Quadrino Schwartz. He is frequently sought-after by the media for insight on criminal cases and issues. Inside Counsel is the nation's leading magazine for in-house counsel in corporate America.